Lipid Metabolism clinical trials

Explore recruiting lipid metabolism clinical trials.

Recruiting lipid metabolism studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Lipid Metabolism trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Effect of Roxadustat on Cardiometabolism

Finland

Therapeutic use (Phase IV) EU CTIS Study details

InvestiGating the rOle of Growth Hormone in hepatic lipid metabolism in humans

Austria

Therapeutic exploratory (Phase II) EU CTIS Study details

Changes in Coronary Plaque Composition By Semaglutide Use in Diabetic Patients With Acute Coronary Syndrome: A Randomized Optical Coherence Tomography Trial - ARMYDA - 10 study

Italy

Therapeutic use (Phase IV) EU CTIS Study details

A randomized, double-blind, placebo-controlled proof-of-concept parallel group clinical trial to investigate the efficacy, safety and tolerability of weekly subcutaneous (SC) dosing of CK-0045 in participants with overweight / obesity and Type 2 diabetes

Germany

Therapeutic exploratory (Phase II) EU CTIS Study details

A Phase IIb, Multicenter, Randomized, Parallel-group, Double- blind, Placebo-controlled, Dose-ranging Study to Evaluate the Efficacy, Safety, and Tolerability of AZD0780 in Participants with Dyslipidemia

Denmark, Czechia, Spain, Slovakia, Hungary

Therapeutic exploratory (Phase II) EU CTIS Study details

A randomised, controlled, parallel group, open-label trial evaluating the impact of treatment with the GLP-1 analogue semaglutide on weight loss in people living with HIV and obesity (SWIFT Study)

Ireland, Denmark, Italy

Therapeutic exploratory (Phase II) EU CTIS Study details

Lipid Metabolism trials by city

Lipid Metabolism in Toronto Lipid Metabolism in Vancouver Lipid Metabolism in Montreal Lipid Metabolism in Calgary Lipid Metabolism in Edmonton Lipid Metabolism in Ottawa Lipid Metabolism in Winnipeg Lipid Metabolism in Quebec City Lipid Metabolism in Hamilton Lipid Metabolism in Kitchener Lipid Metabolism in London Lipid Metabolism in Halifax Lipid Metabolism in New York Lipid Metabolism in Los Angeles Lipid Metabolism in Chicago Lipid Metabolism in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease